International Journal of Tuberculosis and Lung Disease
International Journal of Tuberculosis and Lung Disease is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 124. It has a COP Index of 1,5 (best band Q3). It is published in English. It has a COP Index of 1,5.
International Journal of Tuberculosis and Lung Disease focuses its scope in these topics and keywords: tuberculosis, rifampicin, xpert, susceptibility, probe, distribution, binding, eastern, results, clinical, ...
86 of 134 journals in Pulmonary and Respiratory Medicine
Metrics
Scimago and CountryOfPapers database fields
COP Index
1,5
Q3
SJR Impact
0,975
H-index
124
Docs (year)
133
Docs 3y
680
Total refs
2804
Cites 3y
1013
Citable 3y
362
Cites/Doc 2y
1.41
Ref/Doc
21.08
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Association of CTSZ rs34069356 and MC3R rs6127698 gene polymorphisms with pulmonary tuberculosis
View moreYield of culture of Mycobacterium tuberculosis complex in sputum samples transported from tribal areas
View moreComparative study of the profiles of tribal and non-tribal tuberculosis patients in a tuberculosis unit of West Bengal, India
View moreClinical significance of the radiological severity score in Mycobacterium avium complex lung disease patients
View moreClinical characteristics of patients with tuberculosis-destroyed lung
View moreChildhood tuberculosis and exposure to indoor air pollution: a systematic review and meta-analysis
View moreChanges in treatment outcomes of multidrug-resistant tuberculosis
View moreChange in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status [Short Communication]
View moreCD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001
View moreCapacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis
View moreBronchoscope insertion route and patient comfort during flexible bronchoscopy
View moreBottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India
View moreBioequivalence of fixed-dose combination RIN®-150 to each reference drug in loose combination
View moreA prospective study of mycobacterial viability in refrigerated, unpreserved sputum batched for up to 8 weeks
View moreAscertaining in vivo virulence of Mycobacterium tuberculosis lineages in patients in Mbeya, Tanzania
View moreAre pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?
View moreAnnual risk of tuberculous infection measured using serial skin testing, Orel Oblast, Russia, 1991-2005
View moreAn investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda
View moreAge, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children
View moreAdverse respiratory effects of outdoor air pollution in the elderly [Review article]
View moreAdverse drug reactions in tuberculosis patients: consequences for TB control
View moreAccelerating progress towards tuberculosis elimination: the need for combination treatment and prevention
View moreAbnormal thyroid function tests in children on ethionamide treatment [Short communication]
View moreA systematic review of economic evaluation studies of tuberculosis control in high-income countries
View more